Go to JCI Insight
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Journal stats
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact
  • Clinical Research and Public Health
  • Current issue
  • Past issues
  • By specialty
    • COVID-19
    • Cardiology
    • Gastroenterology
    • Immunology
    • Metabolism
    • Nephrology
    • Neuroscience
    • Oncology
    • Pulmonology
    • Vascular biology
    • All ...
  • Videos
    • ASCI Milestone Awards
    • Video Abstracts
    • Conversations with Giants in Medicine
  • Reviews
    • View all reviews ...
    • The cGAS-STING pathway: DNA sensing in health and disease (Jun 2026)
    • Neurodegeneration (Mar 2026)
    • Clinical innovation and scientific progress in GLP-1 medicine (Nov 2025)
    • Pancreatic Cancer (Jul 2025)
    • Complement Biology and Therapeutics (May 2025)
    • Evolving insights into MASLD and MASH pathogenesis and treatment (Apr 2025)
    • Microbiome in Health and Disease (Feb 2025)
    • View all review series ...
  • Viewpoint
  • Collections
    • In-Press Preview
    • Clinical Research and Public Health
    • Research Letters
    • Letters to the Editor
    • Editorials
    • Commentaries
    • Editor's notes
    • Reviews
    • Viewpoints
    • 100th anniversary
    • Top read articles

  • Current issue
  • Past issues
  • Specialties
  • Reviews
  • Review series
  • ASCI Milestone Awards
  • Video Abstracts
  • Conversations with Giants in Medicine
  • In-Press Preview
  • Clinical Research and Public Health
  • Research Letters
  • Letters to the Editor
  • Editorials
  • Commentaries
  • Editor's notes
  • Reviews
  • Viewpoints
  • 100th anniversary
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Journal stats
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact
Sex-related survival differences in murine cardiomyopathy are associated with differences in TNF-receptor expression
Toshiaki Kadokami, Charles F. McTiernan, Toru Kubota, Carole S. Frye, Arthur M. Feldman
Toshiaki Kadokami, Charles F. McTiernan, Toru Kubota, Carole S. Frye, Arthur M. Feldman
View: Text | PDF
Article

Sex-related survival differences in murine cardiomyopathy are associated with differences in TNF-receptor expression

  • Text
  • PDF
Abstract

Epidemiological evidence suggests that the prognosis of heart failure in women is better than in men. In our murine model of dilated cardiomyopathy arising from cardiac-specific overexpression of TNF-α, the 6-month survival rate was significantly better in females than in males. Young female transgenic mice exhibited left ventricular wall thickening without dilatation, whereas age-matched male transgenic hearts were markedly dilated. Basal and isoproterenol-stimulated fractional shortening was preserved in female transgenic mice, but not in male transgenic mice. Myocardial expression of proinflammatory cytokines and the extent of myocardial infiltrates were similar in male and female transgenic mice. Myocardial expression of TNF-receptor mRNAs (type I and type II) was significantly higher in male mice in both transgenic and wild-type littermates, whereas sex-specific differences were not observed in either peripheral white blood cells or liver tissue. After TNF-α challenge, myocardial but not liver production of ceramide was significantly higher in male than in female mice. Thus, differential expression of myocardial TNF receptors may contribute to sex differences in the severity of congestive heart failure and mortality consequent to cardiac-specific overexpression of TNF-α.

Authors

Toshiaki Kadokami, Charles F. McTiernan, Toru Kubota, Carole S. Frye, Arthur M. Feldman

×

Figure 6

Options: View larger image (or click on image) Download as PowerPoint
Ceramide production in response to acute TNF-α stimulation in FVB mice. ...
Ceramide production in response to acute TNF-α stimulation in FVB mice. Representative images (a) and quantitative results (b) of cardiac-tissue ceramide production. Detectable ceramide mass measured by DAG-kinase assay was significantly greater in male cardiac tissue than in female in the presence of both TNF-α and NOE. Although treatment with TNF-α or NOE alone resulted in significant increase in ceramide production, ceramide mass content was not significantly different between sexes in those groups. Representative images (c) and quantitative results (d) of liver-tissue ceramide production. By contrast to cardiac tissues, additional treatment with NOE plus TNF-α did not result in a significant difference in terms of ceramide production, although the treatment stimulated a substantial amount of ceramide production in both sexes. (e) Dose response of cardiac-tissue ceramide production in the presence of both TNF-α and NOE. Male hearts produced significantly more ceramide in response to both low (200 U/mL) and high (1,000 U/mL) doses of TNF-α. (f) Standard curve of DAG-kinase assay. Note that both samples with low- (A: –TNF-α, –NOE) and high- (B: +TNF-α, +NOE) ceramide content fall within the linear range of the assay. (g) Correlation between total-protein and phospholipid content of the samples. A strong positive correlation was observed between tissue-protein content and phospholipid content (P < 0.005). Ceramide production was expressed as the percentage of control (–TNF-α, –NOE) values, set at 100%. Values are mean ± SD. AP < 0.01 vs. control. BP < 0.05 vs. female (+TNF-α, +NOE). CP < 0.01.

Copyright © 2026 American Society for Clinical Investigation
ISSN: 0021-9738 (print), 1558-8238 (online)

Sign up for email alerts